|
Summary Information: Kiniksa Pharmaceuticals Ltd. Class A Common Stock NASDAQ:KNSA |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa's portfolio of assets, ARCALYST, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases.
__The following are links to various summary and news pages for __Kiniksa Pharmaceuticals Ltd. Class A Common Stock [ KNSA ]. __Note: Some Links might not have information for the company. |
|